Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study (Q34656852)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

anti-retroviral agent

0 references

0 references

10

object named as

J D Lundgren

1 reference

Europe PubMed Central

3 August 2017

1

object named as

A Mocroft

1 reference

Europe PubMed Central

3 August 2017

EuroSIDA study group

11

object named as

EuroSIDA study group

1 reference

Europe PubMed Central

3 August 2017

author name string

A N Phillips

2

1 reference

Europe PubMed Central

3 August 2017

J Gatell

3

1 reference

Europe PubMed Central

3 August 2017

B Ledergerber

4

1 reference

Europe PubMed Central

3 August 2017

M Fisher

5

1 reference

Europe PubMed Central

3 August 2017

N Clumeck

6

1 reference

Europe PubMed Central

3 August 2017

M Losso

7

1 reference

Europe PubMed Central

3 August 2017

A Lazzarin

8

1 reference

Europe PubMed Central

3 August 2017

G Fatkenheuer

9

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 August 2007

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

370

1 reference

Europe PubMed Central

3 August 2017

9585

1 reference

Europe PubMed Central

3 August 2017

407-413

1 reference

Europe PubMed Central

3 August 2017

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological recovery and antiretroviral therapy in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors Associated with the Development of Opportunistic Infections in HIV‐1–Infected Adults with High CD4+Cell Counts: A EuroSIDA Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4+ count-guided interruption of antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960948-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)60948-9

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34656852&oldid=1964251624"